YOLFTbeta
Sernova Corp

Sernova Corp

SVA · TO · Healthcare / Biotechnology

0.11CAD+0.01 (+4.76%)

Price History

Full chart

Market Stats

Previous Close0.105
Open0.11
Day Range0.11 – 0.11
52-Week Range0.09 – 0.20
Volume6.31K
Market Cap41.54M
P/E (TTM)11.00
Forward P/E0.00
EPS0.01
Dividend Yield0.00%
Beta0.64
50-Day Avg0.111
200-Day Avg0.1426

About

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jonathan M. N. Rigby M.B.A.
  • Employees8
  • HeadquartersRPO Central Parkway, Mississauga, ON, Canada, L5A 4H2, Canada
  • Websitehttps://www.sernova.com

Leadership

  • Mr. Jonathan M. N. Rigby M.B.A.President, CEO & Director · b. 1968
  • Mr. James T. Parsons CPA-CA, MAccChief Financial Officer · b. 1965
  • Ms. Marylyn RigbyChief Communications Officer
  • Dr. Pericles Calias Ph.D.Chief Development Officer and Head of R&D · b. 1968
  • Mr. David BurkeVice President of Investor Relations

Financials

Income Statement

Currency: CAD1999-10-312000-10-312001-10-312002-10-312003-10-312004-10-312005-10-312006-10-312007-10-312008-10-312009-10-312010-10-312011-10-312012-10-312013-10-312014-10-312015-10-312016-10-312017-10-312018-10-312019-10-312020-10-312021-10-312022-10-312023-10-312024-10-312025-10-31
Total Revenue--81.33K16.90K132.74K88.01K5.28K--80.30K-------0000000000
Growth (%)----79.22%+685.65%-33.70%-94.00%--------------------
Cost of Revenue-----43.73K-----------7.56K39.87K64.53K61.48K225.23K267.20K440.00K445.55K540.28K342.59K
Gross Profit--81.33K16.90K132.74K44.28K5.28K--80.30K--------7.56K-39.87K-64.53K-61.48K-225.23K-267.20K-440.00K-445.55K-540.28K-342.59K
Gross Margin--100.00%100.00%100.00%50.31%100.00%--100.00%-----------------
Operating Expense--2.22M1.51M842.60K657.49K430.94K--2.80M-------2.48M2.59M3.62M3.91M5.00M6.60M23.74M40.69M31.30M14.78M
Operating Income-30.58K-422.08K-2.14M-1.50M-709.86K-613.21K-425.66K-1.34M-3.72M-2.72M-1.49M-1.84M-2.03M-2.60M-2.07M-2.79M-2.85M-2.49M-2.63M-3.69M-3.97M-5.22M-6.87M-24.18M-41.13M-31.84M-15.12M
Operating Margin---2631.21%-8855.05%-534.76%-696.77%-8055.66%---3381.85%-----------------
EBITDA-30.58K-453.21K-2.12M-1.48M-699.33K-585.81K-423.30K-1.22M-2.92M-2.38M-655.66K-992.40K-1.14M-1.92M-1.35M-2.01M-2.39M-2.49M-2.60M-3.64M-3.95M-5.56M-6.60M-24.54M-40.19M-31.25M-14.74M
EBITDA Margin---2610.26%-8767.16%-526.83%-665.63%-8011.03%---2965.12%-----------------
Net Income-21.68K-422.08K-2.14M-1.50M-709.86K-368.37K-433.56K-1.26M-3.59M-2.75M-1.47M-1.85M-2.02M-2.57M-2.00M-2.75M-2.86M-2.50M-2.64M-3.70M-3.98M-5.41M-7.02M-24.54M-39.00M-32.19M-15.74M
Net Income Margin---2631.21%-8855.05%-534.76%-418.57%-8205.22%---3428.83%-----------------
R&D--1.11M397.99K171.97K115.07K-258.28K1.25M816.80K20.08K276.76K415.25K386.09K1.57M1.94M1.79M1.20M1.54M2.23M2.01M2.76M4.64M16.90M32.26M22.36M7.28M
R&D as % of Total Revenue--1363.25%2355.52%129.55%130.74%---1017.13%-----------------
Interest Expense-----244.84K7.90K19.10K33.58K37.72K4.06K55813.04K3.95K1.58K3.65K5.78K9.69K13.84K9.71K7.27K86.28K58.37K118.00K32.08K586.86K754.81K
Interest Expense % of Total Revenue-----278.20%149.56%--46.97%-----------------

Balance Sheet

Currency: CAD1999-10-312000-10-312001-10-312002-10-312003-10-312004-10-312005-10-312006-10-312007-10-312008-10-312009-10-312010-10-312011-10-312012-10-312013-10-312014-10-312015-10-312016-10-312017-10-312018-10-312019-10-312020-10-312021-10-312022-10-312023-10-312024-10-312025-10-31
Total Assets442.69K2.40M1.78M574.92K401.24K336.98K491.66K6.70M7.23M5.15M4.49M4.03M3.98M6.20M6.24M4.02M3.15M6.23M4.55M3.61M5.57M5.73M29.82M52.48M22.11M7.53M764.23K
Total Liabilities-134.08K447.63K187.68K182.39K174.78K242.24K122.15K34.29K120.84K102.22K144.00K119.07K133.95K225.15K240.09K199.85K846.27K901.07K341.20K686.82K1.58M1.75M4.88M9.59M20.48M25.84M
Total Equity416.94K2.27M1.34M387.24K218.85K162.20K249.42K6.57M7.20M5.03M4.39M3.89M3.86M6.07M6.02M3.78M2.95M5.38M3.65M3.26M4.88M4.14M28.07M47.61M12.51M-12.96M-25.08M
Cash401.26K294.41K1.58M341.93K129.00K278.19K374.34K2.87M1.80M461.35K396.96K735.14K309.99K255.56K273.61K463.81K211.94K5.20M2.63M1.74M1.80M3.95M27.87M3.78M8.72M6.01M265.00K
Total Debt-----92.65K87.65K--------------734.39K393.36K275.98K136.12K569.94K4.77M
Net Debt-401.26K-294.41K-1.58M-341.93K-129.00K-185.54K-286.69K-2.87M-1.80M-461.35K-396.96K-735.14K-309.99K-255.56K-273.61K-463.81K-211.94K-5.20M-2.63M-1.74M-1.80M-3.25M-27.48M-3.50M-8.59M-5.44M4.51M

Cash Flow

Currency: CAD1999-10-312000-10-312001-10-312002-10-312003-10-312004-10-312005-10-312006-10-312007-10-312008-10-312009-10-312010-10-312011-10-312012-10-312013-10-312014-10-312015-10-312016-10-312017-10-312018-10-312019-10-312020-10-312021-10-312022-10-312023-10-312024-10-312025-10-31
Operating Cash Flow-2.22K-407.84K-1.71M-1.72M-701.68K-648.09K-239.10K-758.63K-2.23M-1.25M-574.20K-825.73K-901.18K-1.57M-1.21M-1.70M-2.16M-2.55M-2.74M-3.92M-4.19M-3.94M-6.84M-14.42M-30.34M-18.90M-10.91M
Investing Cash Flow--107.73K-33.29K-26.18K-27.72K408.64K-98.03K-130.59K-1.32M-89.68K-148.48K-72.27K-1.30M-2.92M-611.16K1.65M162.29K1.93M-551.69K-110.66K-1.02M994.37K-228.78K-46.34M34.78M11.12M24.96K
Financing Cash Flow205.48K1.87M1.88M509.74K516.47K388.65K433.27K3.39M2.48M-658.29K1.24M1.77M4.43M1.83M242.78K1.75M5.61M720.11K3.14M5.27M5.10M31.00M36.66M503.46K5.07M5.14M
Capital Expenditure0457.53K8.67K5.39K27.72K00100.99K1.32M89.68K148.48K72.27K98.81K52.91K61.16K122.31K86.64K19.45K251.69K115.03K24.00K1.01M17.23K329.00K99.26K33
Free Cash Flow-2.22K-865.37K-1.72M-1.73M-729.40K-648.09K-239.10K-859.62K-3.55M-1.34M-722.68K-898.00K-999.99K-1.62M-1.27M-1.83M-2.25M-2.57M-2.99M-4.03M-4.22M-4.94M-6.86M-14.75M-30.44M-18.90M-10.91M
FCF to OCF100.00%212.18%100.51%100.31%103.95%100.00%100.00%113.31%159.53%107.18%125.86%108.75%110.96%103.37%105.08%107.18%104.00%100.76%109.18%102.94%100.57%125.53%100.25%102.28%100.33%100.00%100.00%

Earnings

Report DateJan 18, 2016Oct 31, 2021Feb 13, 2022Jun 27, 2022Sep 14, 2022Jan 27, 2023Mar 16, 2023Jun 13, 2023Sep 12, 2023Jan 29, 2024Mar 18, 2024Jun 14, 2024Sep 16, 2024Dec 23, 2024Mar 14, 2025Jun 13, 2025Sep 15, 2025Dec 19, 2025Mar 13, 2026Jun 11, 2026Sep 10, 2026Dec 17, 2026
EPS Estimate0.00-0.01-0.01-0.01-0.02--0.02-0.02-0.02-0.02-0.03-0.02-0.03-0.03-0.03-0.02-0.01-0.01-0.01-0.01-0.01-0.01
EPS Actual-0.01-0.01-0.02-0.02-0.02-0.03-0.03-0.03-0.03-0.04-0.03-0.03-0.02-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-
Surprise-0.00%-100.00%-100.00%0.00%--50.00%-50.00%-50.00%-100.00%0.00%-50.00%33.33%33.33%33.33%50.00%0.00%0.00%0.00%0.00%0.00%-
TimingAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap41.54M
Enterprise Value50.42M
Trailing P/E11.00
Forward P/E0.00
Price / Sales65.86
Price / Book24.15
EPS0.01
Book Value-0.063
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-8.94M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-726.29%
Return on Assets-868.43%
Shares Outstanding377.64M
Shares Float326.77M
Beta0.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 27, 19991:3